ReviewClinical hematology international2023

Refractory Anaplastic Large Cell Lymphoma Rescued by the Combination of the Second-Generation ALK Inhibitor Brigatinib, High-dose Chemotherapy and Allogeneic Stem Cell Transplantation: A Case Report and Review of the Literature.

Giulia Caddeo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.